Skip to main content

Part of the book series: Infectious Disease ((ID))

Abstract

Several advances have occurred in our knowledge of the natural history and management of bronchitis. The first step has been a classification of patients with chronic bronchitis into four groups (see Table 1) (1). Chronic bronchitis is a syndrome defined by cough and production of sputum on most days for at least 3 months a year for 2 consecutive years (2). It is often complicated by airway obstruction leading to the commonly used term chronic obstructive pulmonary disease (COPD).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wilson, R. and Wilson, C.B. (1997) Defining subsets of patients with chronic bronchitis. Chest 112, 3035–309S.

    Article  Google Scholar 

  2. Medical Research Council (1965) Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1, 775–779.

    Google Scholar 

  3. Grossman, R.F. (1997) Guidelines for the treatment of acute exacerbations of chronic bronchitis. Chest 112, 310S–313S.

    Article  PubMed  CAS  Google Scholar 

  4. US Bureau of the Census (1994) Statistical abstract of the United States, 114th edition, US Bureau of the Census, Washington DC: p. 95.

    Google Scholar 

  5. Ball, P. (1998) Infective pathogenesis and outcomes in chronic bronchitis. Curr. Opin. Pulm. Med. 2, 161–165.

    Google Scholar 

  6. Eller, J., Ede, A., Schaberg, T., et al (1998). Infective exacerbations of chronic bronchitis. Relation between bacterial etiology and lung function. Chest 113, 1542–1548.

    Article  PubMed  CAS  Google Scholar 

  7. Saint, S., Bent, S., Vittinghoff, E., et al. (1995). Antibiotics in chronic obstructive pulmonary disease exacerbatons. JAMA 273, 957–960.

    Article  PubMed  CAS  Google Scholar 

  8. Chodosh, S., Schreurs, A., Siami, G., et al., and the Bronchitis Study Group (1998) Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. Clin. Infect. Dis. 27, 730–738.

    Google Scholar 

  9. Chodosh, S., McCarty, J., Farkas, S., et al., and the Bronchitis Study Group (1998) Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. Clin. Infect. Dis. 27, 722–729

    Google Scholar 

  10. Canadian Thoracic Society Workshop Group (1992) Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can. Med. Assoc. J. 147, 420–428.

    Google Scholar 

  11. Seneff, M.G., Wagner, D.P., Wagner, R.P., et al. (1995) Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbations of chronic obstructive pulmonary disease. JAMA 274, 1852–1857.

    Article  PubMed  CAS  Google Scholar 

  12. Torres, A., Dorca, J., Zalacain, R., et al. (1996) Community-acquired pneumonia in chronic obstructive pulmonary disease. A Spanish multicenter study. Am. J. Respir. Crit. Care Med. 154, 1456–1461.

    Article  PubMed  CAS  Google Scholar 

  13. Dixon, R.E. (1985) Economic costs of respiratory tract infections in the United States. Am. J. Med. 78, 45–51.

    Article  PubMed  CAS  Google Scholar 

  14. National Center for Health Statistics (1992) National hospital discharge survey: annual summary, 1990. Vital Health Stat. 13, 1–225.

    Google Scholar 

  15. Koivula, I., Stenn, M., and Makela, P.H. (1994). Risk factors for pneumonia in the elderly. Am. J. Med. 96, 313–320.

    Article  PubMed  CAS  Google Scholar 

  16. Lipsky, B.A., Boyko, E.J., Inui, T.S., et al. (1986) Risk factors for acquiring pneumococcal infections. Arch. Intern. Med. 146, 2179–2185.

    Article  PubMed  CAS  Google Scholar 

  17. Plouffe J.F., Breiman R.E., and Facklam, R.R., for the Franklin County Pneumonia Study Group. (1996) Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. JAMA 275, 194–198.

    Article  Google Scholar 

  18. Marston B.J, Lipman, H.B. and Breiman, R.F. (1994) Surveillance for Legionnaires’ disease. Risk factors for morbidity and mortality. Arch. Intern. Med. 154, 2417–2422.

    Article  PubMed  CAS  Google Scholar 

  19. Butler, J.C., Hofmann, J., Cretron, M.S., et al. (1996) The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention’s surveillance system. J. Infect. Dis. 74, 986–993.

    Article  Google Scholar 

  20. Moreno, S., Garcia-Leoni M.E., Cercenado, E., et al. (1995) Infections caused by erythromycin-resistant Streptococcus pneumoniae. Incidence, risk factors, and response to therapy in a prospective study. Clin. Infect. Dis. 20, 1195–1200.

    Article  PubMed  CAS  Google Scholar 

  21. Clavo-Sanchez, A.J., Giron-Gonzalez, J.A., Lopez-Prieto, D., et al. (1997) Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study. Clin. Infect. Dis. 24, 1052–1059.

    Article  PubMed  CAS  Google Scholar 

  22. Nava, J.M., Bella, F., Garau, J., et al. (1994) Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin. Infect. Dis.19, 884–890.

    Google Scholar 

  23. Flournoy, D.J. Stalling, F.H., and Catron, T.L. (1983) Seasonal and monthly variation of Streptococcus pneumoniae and other pathogens in bacteremia (1961–1981) Ecol. of Dis. 2 157–160.

    Google Scholar 

  24. Berendt, R.F., Long, G.G., and Walker, J.S. (1975) Influenza alone and in sequence with pneumonia due to Streptococcus pneumoniae in the squirrel monkey. J. Infect. Dis. 132, 689–693.

    Article  PubMed  CAS  Google Scholar 

  25. Berntsson, E., Lagergard, T., Strannegard, O., et al. (1986) Etiology of community-acquired pneumonia in outpatients. Europ. J. Clin. Microbiol. 5, 446–447.

    Article  CAS  Google Scholar 

  26. Marrie, T.J, Peeling, R.W., Fine, M.J., et al. (1996) Ambulatory patients with community-acquired pneumonia. The frequency of atypical agents and clinical course. Am. J. Med. 101, 508–515.

    Article  PubMed  CAS  Google Scholar 

  27. Erard, P.H., Moser, F., Wenger, A., et al. (1991) Prospective study on community-acquired pneumonia diagnosed and followed up by private practitioner. Abstracts of the 1991 Interscience Conference on Antimicrobal Agents and Chemotherapy. Am. Soc. for Microbiol. 108, 56A.

    Google Scholar 

  28. Langille, D.B., Yates, L., and Marrie,T.J. (1993). Serological investigation of pneumonia as it presents to the physicians office. Can. J. Infect. Dis. 4, 328–332.

    PubMed  CAS  Google Scholar 

  29. Porath, A., Schlaeffer, F., and Liberman, D. (1997). The epidemiology of community-acquired pneumonia among hospitalized patients. J. Infect. 34, 41–48.

    Article  PubMed  CAS  Google Scholar 

  30. Burman, L.A., Trollfors, B., Andersen, B., et al. (1993). Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigen. J. Infect. Dis. 163, 1087–1093.

    Google Scholar 

  31. Boht, R., van Furth, R., and van den Broek, P.J. (1995) Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 50, 543–547.

    Article  Google Scholar 

  32. Mundy, L.M., Aurwaeter, P.G., Oldach, D., et al. (1995) Community-acquired pneumonia: impact of immune status. Am. J. Respir. Crit. Care Med. 152, 1309–1315.

    Article  PubMed  CAS  Google Scholar 

  33. Marston, B.J. Plouffe, J.F., File, T.M., Jr., et al. (1997) Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch. Intern. Med. 157 1709–1817.

    Google Scholar 

  34. Marrie, T.J., Durant, H., and Yates, L. (1989) Community-acquired pneumonia requiring hospitalization. Rev. Infect. Dis. 11, 586–599.

    Google Scholar 

  35. Kauppinen, M.T., Herva, E., Kujala, P., et al. (1995) The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J. Infect. Dis. 172, 1330–1335.

    Google Scholar 

  36. Levy, M., Dromer, F., Brion, N., et al. (1998) Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations. Chest 93, 43–48.

    Article  Google Scholar 

  37. Fang, G. D., Fine, M., Orleff, J., et al. (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine 69, 307–316.

    Google Scholar 

  38. Valenti, W.M., Trudell, R.G., and Bentley, D.W. (1978) Factors predisposing to oropharyngeal colonization with gram negative bacilli in the aged. N. Engl. J. Med. 298, 1108–1111.

    Article  PubMed  CAS  Google Scholar 

  39. Garb, J.L, Brown R.B, Garb, J., et al. (1978) Differences in etiology of pneumonias in nursing home and community patients. JAMA 240, 2169–2172

    Article  PubMed  CAS  Google Scholar 

  40. Orr, P.H., Peeling, R.W., Fast, M., et al. (1996) Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly. Clin. Infect. Dis. 23, 1240–1248.

    Article  PubMed  CAS  Google Scholar 

  41. Phillips, S.L. and Branaman-Phillips, J. (1993). The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home acquired pneumonia. J. Am. Geriatr. Soc. 41, 1071–1074.

    PubMed  CAS  Google Scholar 

  42. Drinka, P.J., Gauerke, C., Voeks, S., et al. (1994) Pneumonia in a nursing home. J. Gen. Intern. Med. 9, 650–652

    Article  PubMed  CAS  Google Scholar 

  43. Chow, C.W., Senathiragah, N., Rawji, M., et al. (1994) Interim report on drug utilization review of community-acquired and nosocomial pneumonia: clinical bacteriological and radiological spectrum. Can. J. Infect. Dis. 5(Suppl. C), 20C–27C.

    Google Scholar 

  44. Marrie, T.J., Haldone, E.F., Faulkner, R.S., et al. (1985) Community-acquired pneumonia requiring hospitalization. Is it different in the elderly? J. Am. Geriatr. Soc. 33, 671–680.

    PubMed  CAS  Google Scholar 

  45. Fein, A.M. (1994) Pneumonia in the elderly. Special diagnostic and therapeutic considerations. Med. Clin. North Am. 78, 1015–1033.

    PubMed  CAS  Google Scholar 

  46. Granton, J.T. and Grossman, R.F. (1993) Community-acquired pneumonia in the elderly patient. Clinical features, epidemiology, and treatment. Clin. Chest. Med. 14, 537–552.

    PubMed  CAS  Google Scholar 

  47. Fine, M.J., Auble, T.E., Yealy, D.M., et al. (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336, 243–250.

    Article  PubMed  CAS  Google Scholar 

  48. Atlas, S.J., Benzer, T.I., Borowsky, L.H., et al. (1998) Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients. Arch. Intern. Med. 158, 1350–1356.

    Article  PubMed  CAS  Google Scholar 

  49. Marrie, T. Lau, C., Feagan, B., et al. (1998) A randomized controlled trial of a critical pathway for the management of community-acquired pneumonia. 6th International Quinolone Meeting, Nov. 16–18, Denver, CO.

    Google Scholar 

  50. Niederman, M.S., Best, J.B., Campbell, G.D., et al. (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am. Rev. Respir. Dis. 148, 1418–1426.

    Article  PubMed  CAS  Google Scholar 

  51. Ewig, S., Ruiz, M., Mensa, J., et al. (1988) Severe community-acquired pneumonia. Assessment of severity criteria. Am. J. Respir. Crit. Care Med. 158, 1102–1108.

    Article  Google Scholar 

  52. Ramirez, J.A., Srinath, L., Ahkee, S., et al. (1995) Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch. Intern. Med. 155, 1273–1276.

    Article  PubMed  CAS  Google Scholar 

  53. Ramirez, J.A. and Ahkee, S. (1997) Early switch from intravenous antimicrobial to oral clarithromycin in patients with community-acquired pneumonia. Infect. Med. 14, 319–323.

    Google Scholar 

  54. Ramirez, J.A. (1995) Switch therapy in adult patients with pneumonia. Clin. Pulm. Med. 2, 327–333.

    Article  Google Scholar 

  55. Meehan, T.P., Fine, M.J., Krumholz, H.M. et al. (1997) Quality of care, process and outcomes in elderly patients with pneumonia. JAMA 278, 2080.

    Article  PubMed  CAS  Google Scholar 

  56. Halm, E.A., Fine, M.J., Marrie, T.J., et al (1998) Time to clinical stability in patients hospitalized with community-acquired pneumonia. Implications for practice guidelines. JAMA 279, 1452–1457.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Marrie, T.J. (2001). Bronchitis and Pneumonia. In: Yoshikawa, T.T., Norman, D.C. (eds) Infectious Disease in the Aging. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-026-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-026-1_6

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5459-9

  • Online ISBN: 978-1-59259-026-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics